Quantum Genomics Societe Anonyme (0D1J) Ratios
Quantum Genomics Societe Anonyme Ratios
GB:0D1J's free cash flow for Q4 2024 was $0.00. For the 2024 fiscal year, GB:0D1J's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.05 | 2.73 | 1.33 | 2.57 | 4.38 |
| Quick Ratio | 2.05 | 2.73 | 1.33 | 2.57 | 4.14 |
| Cash Ratio | 1.75 | 2.63 | 0.59 | 1.72 | 3.73 |
| Solvency Ratio | -3.16 | -0.88 | -1.23 | -1.47 | -1.97 |
| Operating Cash Flow Ratio | 0.00 | 0.00 | -1.15 | -2.16 | -1.65 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | -104.40 | -47.59 |
| Net Current Asset Value | $ -2.46M | $ 377.14K | $ 3.34M | $ 8.66M | $ 23.68M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 7.44 | 0.73 | 0.13 | 0.16 | 0.03 |
| Debt-to-Equity Ratio | -1.07 | 6.22 | 0.84 | 0.36 | 0.04 |
| Debt-to-Capital Ratio | 14.44 | 0.86 | 0.46 | 0.26 | 0.03 |
| Long-Term Debt-to-Capital Ratio | 14.44 | 0.82 | 0.46 | 0.23 | 0.02 |
| Financial Leverage Ratio | -0.14 | 8.58 | 6.56 | 2.20 | 1.33 |
| Debt Service Coverage Ratio | -1.82 | -3.65 | -1564.64 | -80.97 | -7.38 |
| Interest Coverage Ratio | -53.51 | -146.59 | -1702.31 | -437.24 | -11.56 |
| Debt to Market Cap | 0.68 | 0.74 | 0.74 | 0.03 | 0.01 |
| Interest Debt Per Share | 0.04 | 0.08 | 0.09 | 0.13 | 0.11 |
| Net Debt to EBITDA | -1.59 | 0.29 | 0.24 | 0.52 | 1.79 |
| Profitability Margins | |||||
| Gross Profit Margin | -11453070.00% | -7169.57% | -1073.02% | -548.31% | -814.93% |
| EBIT Margin | -14728340.00% | -15847.91% | -1211.23% | -631.10% | -757.66% |
| EBITDA Margin | -14702370.00% | -14515.46% | -1200.75% | -618.67% | -802.24% |
| Operating Profit Margin | -14728350.00% | -15847.92% | -1196.12% | -640.95% | -920.28% |
| Pretax Profit Margin | -88926030.00% | -16192.05% | -1092.80% | -632.57% | -1000.00% |
| Net Profit Margin | -88926030.00% | -16018.12% | -991.45% | -553.19% | -887.04% |
| Continuous Operations Profit Margin | -88926030.00% | -16018.12% | -991.45% | -553.19% | -887.04% |
| Net Income Per EBT | 100.00% | 98.93% | 90.72% | 87.45% | 88.70% |
| EBT Per EBIT | 603.77% | 102.17% | 91.36% | 98.69% | 108.66% |
| Return on Assets (ROA) | -2507.44% | -84.63% | -105.40% | -81.72% | -49.46% |
| Return on Equity (ROE) | 362.09% | -726.18% | -691.19% | -179.57% | -65.81% |
| Return on Capital Employed (ROCE) | -806.14% | -130.88% | -495.72% | -150.38% | -65.93% |
| Return on Invested Capital (ROIC) | -153.05% | -98.42% | -452.26% | -128.73% | -57.62% |
| Return on Tangible Assets | -2507.44% | -84.63% | -105.40% | -83.84% | -50.63% |
| Earnings Yield | -176.93% | -85.82% | -612.03% | -15.02% | -16.22% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.19 | 4.51 | 0.48 |
| Payables Turnover | 7.88 | 5.29 | 1.84 | 3.02 | 2.83 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 9.58 |
| Fixed Asset Turnover | 0.01 | 2.51 | 109.58 | 7.10 | 10.10 |
| Asset Turnover | 0.00 | 0.01 | 0.11 | 0.15 | 0.06 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.28 | 0.17 | 0.11 |
| Cash Conversion Cycle | 1001550.16 | -69.04 | 1674.06 | -40.08 | 676.76 |
| Days of Sales Outstanding | 1001596.50 | 0.00 | 1872.11 | 80.96 | 767.81 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 38.10 |
| Days of Payables Outstanding | 46.34 | 69.04 | 198.05 | 121.03 | 129.15 |
| Operating Cycle | 1001596.50 | 0.00 | 1872.11 | 80.96 | 805.91 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | 0.00 | -0.59 | -0.63 | -0.59 |
| Free Cash Flow Per Share | 0.00 | 0.00 | -0.59 | -0.63 | -0.61 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | -378.16 | -29.18 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | -378.16 | -29.18 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | -6.66 | -4.92 | -13.57 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | -8.04 | -5.42 | -6.56 |
| Free Cash Flow Yield | 0.00% | 0.00% | -496.12% | -14.76% | -12.40% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.57 | -1.17 | -0.16 | -6.66 | -6.16 |
| Price-to-Sales (P/S) Ratio | 502592.05 | 186.65 | 1.62 | 36.83 | 54.68 |
| Price-to-Book (P/B) Ratio | -2.05 | 8.46 | 1.13 | 11.95 | 4.06 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.00 | 0.00 | -0.20 | -6.77 | -8.06 |
| Price-to-Operating Cash Flow Ratio | 0.00 | 0.00 | -0.20 | -6.79 | -8.34 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.01 | -0.01 | 0.35 | -0.11 |
| Enterprise Value Multiple | -5.01 | -1.00 | 0.11 | -5.43 | -5.03 |
| Enterprise Value | 7.36M | 2.86M | -3.29M | 105.47M | 73.75M |
| EV to EBITDA | -5.01 | -1.00 | 0.11 | -5.43 | -5.03 |
| EV to Sales | 736354.75 | 144.69 | -1.31 | 33.61 | 40.32 |
| EV to Free Cash Flow | 0.00 | 0.00 | 0.16 | -6.18 | -5.95 |
| EV to Operating Cash Flow | 0.00 | 0.00 | 0.16 | -6.20 | -6.15 |
| Tangible Book Value Per Share | -0.04 | 0.01 | 0.10 | 0.34 | 1.17 |
| Shareholders’ Equity Per Share | -0.04 | 0.01 | 0.10 | 0.36 | 1.21 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.01 | 0.09 | 0.13 | 0.11 |
| Revenue Per Share | 0.00 | 0.00 | 0.07 | 0.12 | 0.09 |
| Net Income Per Share | -0.13 | -0.09 | -0.72 | -0.64 | -0.79 |
| Tax Burden | 1.00 | 0.99 | 0.91 | 0.87 | 0.89 |
| Interest Burden | 6.04 | 1.02 | 0.90 | 1.00 | 1.32 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 32230.30 | 0.00 | 0.00 | 5.32 | 6.73 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.50 | 0.81 |
| Income Quality | 0.00 | 0.00 | 0.81 | 0.98 | 0.74 |
Currency in EUR
